BIVIX | NLSIX | BIVIX / NLSIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 13 years | - |
Gain YTD | -10.532 | 4.756 | -221% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000 | 1000000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.18B | 7.13B | 16% |
Annual Yield % from dividends | 2.62 | 0.63 | 415% |
Returns for 1 year | -22.19 | 7.91 | -280% |
Returns for 3 years | 7.38 | 3.46 | 213% |
Returns for 5 years | 62.13 | 26.13 | 238% |
Returns for 10 years | N/A | 42.10 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EIHSX | 15.88 | N/A | N/A |
Eaton Vance Worldwide Health Sci I | |||
MLPRX | 4.66 | -0.01 | -0.21% |
Invesco SteelPath MLP Income C | |||
SGISX | 34.61 | -0.12 | -0.35% |
Steward Global Equity Income Fund I | |||
ABIYX | 16.22 | -0.06 | -0.37% |
AB International Value Advisor | |||
RNPBX | 59.64 | -0.26 | -0.43% |
American Funds New Perspective R2 |